Fig. 11From: Co-axial electrospraying of injectable multi-cancer drugs nanocapsules with polymer shells for targeting aggressive breast cancersThe efficacy of encapsulated paclitaxel plus GW2580 on survival of 4T1 tumor-bearing immune deficient NSG mice. In vivo tumor growth (luciferase expressing 4T1 breast cancer cells) and animal survival using the injectable PCL-encapsulated paclitaxel plus GW2580. Kaplan–Meier analyses showed significant survival benefit with nanonized drug combinationBack to article page